Summary by Moomoo AI
On August 5, 2024, Hualing Pharmaceuticals (stock code: 02552.HK) submitted the latest monthly securities transaction report to Hong Kong Exchanges and Clearing Limited, reporting the changes in the company's share capital as of July 31, 2024. The report shows that the company's statutory/registered share capital and the number of issued shares remained unchanged in that month, with a total of 2,000,000,000 shares, with a face value of 0.001 US dollars per share, and the total statutory/registered share capital is 2,000,000 US dollars. At the same time, the number of the company's issued shares (excluding treasury shares) remained at 1,055,588,761 shares. In addition, there was no change in the company's share option plan in that month, and there was no issuance of new shares or treasury shares. The report also confirms that all securities issuances or transfers of treasury shares have been authorized by the board of directors and comply with relevant listing rules and regulations.
